UK-based company 32Co unveils widespread Sleep Centre network, aiming to address escalating sleep disorder emergency
London-based healthtech company, 32Co, is set to revolutionize sleep apnoea and snoring treatment with the launch of its nationwide network of Aerox Sleep Centres this summer. This expansion, supported by Professor Ama Johal, a world-renowned Dental Sleep Medicine expert, aims to address gaps in care by providing more widespread availability of effective devices, specifically mandibular advancement devices (MADs)[1].
The Aerox Sleep Centres focus on the use of MADs, oral appliances designed to improve airway patency during sleep by advancing the lower jaw forward. These devices have been shown to have 25% higher adherence than Continuous Positive Airway Pressure (CPAP) machines, with similar improvements in Excessive Daytime Sleepiness (EDS) and Quality of Life (QoL)[2].
By establishing more Aerox Sleep Centres, 32Co is upskilling dentists across the UK to diagnose and manage sleep apnoea effectively, thereby expanding the market reach for sleep disorder treatments in dental settings. This model increases patient accessibility, especially for those reluctant or unable to use CPAP machines due to their intrusive nature, causing many patients to stop treatment due to discomfort, claustrophobia, and travel difficulties[2].
The availability of Aerox Sleep Centres addresses a critical healthcare need, improving patient outcomes by reducing untreated sleep apnoea and associated risks. These risks include depression, memory loss, diabetes, and fatigue-related accidents[2]. In fact, around 8 million people aged 30-69 years might be affected by Obstructive Sleep Apnoea (OSA) in the UK alone[2].
The first pilot centres will be in London, Manchester, Edinburgh, and Bristol, with new centres to launch nationwide. The expansion reflects growing demand for non-invasive and patient-friendly treatment options, fueling growth in the dental sleep medicine sector[1][2].
Testimonials from early adopters of the MADs and Aerox Sleep Centres have been overwhelmingly positive. John, 69, from Manchester, stated that he would sleep downstairs with the dog if his device broke, while Michael, 58, from London, reported that he no longer wakes up as tired as he normally does due to the device[3]. Helen, 64, from London, believes that many people would benefit from MADs as they are unobtrusive[4].
A national waitlist is now open for patients in other regions. For more information and to join the waitlist, visit the 32Co website[5].
References:
[1] 32Co (2023). Aerox Sleep Centres: Revolutionizing Sleep Apnoea and Snoring Treatment. Retrieved from https://www.32co.com/aerox-sleep-centres
[2] 32Co (2023). Sleep Apnoea Treatment with MADs: Benefits, Accessibility, and Market Growth. Retrieved from https://www.32co.com/sleep-apnoea-treatment-with-mads
[3] 32Co (2023). Personal Testimonials: The Impact of MADs and Aerox Sleep Centres. Retrieved from https://www.32co.com/personal-testimonials
[4] 32Co (2023). The Growing Demand for Non-Invasive Sleep Apnoea Treatments. Retrieved from https://www.32co.com/growing-demand-for-non-invasive-sleep-apnoea-treatments
[5] 32Co (2023). Join the Aerox Sleep Centres Waitlist. Retrieved from https://www.32co.com/join-the-waitlist
- 32Co's expansion of Aerox Sleep Centres across the UK catalyzes improvement in dental settings by facilitating the diagnosis and management of sleep apnoea, boosting the digital health sector through the use of medical plastics for mandibular advancement devices (MADs).
- The strategic growth in the number of Aerox Sleep Centres showcases science-backed solutions for chronic diseases like sleep apnoea, enhancing overall health-and-wellness, and fitness-and-exercise by alleviating sleep-related conditions.
- With a confirmed patient-friendly approach using dental settings, Aerox Sleep Centres reduce the risks associated with untreated sleep apnoea, such as depression, memory loss, diabetes, and fatigue-related accidents, thus benefitting millions of individuals in the UK struggling with Obstructive Sleep Apnoea (OSA).
- By offering an unobtrusive and non-invasive sleep apnoea treatment through MADs, 32Co fosters a positive health-and-wellness experience, further igniting the demand for medical plastics in digital health, revolutionizing the sector and extending treatment options for chronic diseases.
